Olmeraas CH 20mg/12.5mg Tablet
Marketer
Zenni Pharmaceutical Private Limited
Salt Composition
Olmesartan Medoxomil (20mg) + Chlorthalidone (12.5mg)
Overview Olmeraas CH 20mg/12.5mg Tablet
Each Olmeraas CH 20mg/12.5mg tablet combines two active ingredients to manage hypertension through complementary mechanisms. Untreated high blood pressure significantly increases the risk of stroke, heart attack, and kidney disease. Olmeraas CH can be taken with or without food, the dosage tailored to individual response and medical history. Consistent daily timing is recommended. Continuous use, as directed by your physician, is crucial; discontinuation may elevate stroke or heart attack risk. This medication includes a diuretic, increasing urination, so avoid taking it within four hours of bedtime. Regular use, even during symptom-free periods, maximizes therapeutic benefit. High blood pressure often lacks noticeable symptoms. Dizziness is a common side effect; others include fatigue, nausea, diarrhea, headache, and hypotension. Increased urination is a intended effect of the chlorthalidone component, aiding blood pressure control. While other side effects are possible, most are infrequent. Consult the patient information leaflet and inform your doctor of persistent or bothersome side effects; dosage adjustment or alternative therapies may be considered. This medication is not advised during pregnancy and requires prior physician consultation if you have kidney or liver impairment, cardiac issues, or diabetes. Alcohol consumption may exacerbate hypotension and side effects.
Primary Ingredients of Olmeraas CH 20mg/12.5mg Tablet
No text was provided to rewrite.
Uses of Olmeraas CH 20mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Olmeraas CH 20mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Olmeraas CH 20mg/12.5mg Tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, though consistent daily timing is recommended.
Common Side effects of Olmeraas CH 20mg/12.5mg Tablet:
- Nausea
- Taste change
- Diarrhea
- Upset stomach
- Weakness
- Headache
- Increased blood uric acid
- Dizziness
- Increased blood lipid level
- Electrolyte imbalance
- Decreased blood pressure
- Urinary tract infection
- Renal dysfunction
- Sore throat
- Abnormal liver function tests
- Increased potassium level in blood
How to use Olmeraas CH 20mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Olmeraas CH 20mg/12.5mg Tablet whole; do not chew, crush, or divide it. While consumption with or without food is acceptable, maintaining a consistent administration time is recommended.
How Olmeraas CH 20mg/12.5mg Tablet works:
Each Olmeraas CH tablet (20mg/12.5mg) contains a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Olmeraas CH 20mg/12.5mg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Olmeraas CH 20mg/12.5mg tablets is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of Olmeraas CH 20mg/12.5mg tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Olmeraas CH 20mg/12.5mg tablets may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
For individuals with severe kidney impairment, the administration of Olmeraas CH 20mg/12.5mg tablets requires careful consideration. Dosage modification of Olmeraas CH 20mg/12.5mg tablets may be necessary; physician consultation is advised. Prescribing Olmeraas CH 20mg/12.5mg tablets is not advisable in such cases.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Olmeraas CH 20mg/12.5mg tablets, as dose modification may be necessary. Severe liver disease contraindicates the use of Olmeraas CH 20mg/12.5mg tablets; physician consultation is advised.
What if you forget to take Olmeraas CH 20mg/12.5mg Tablet :
Should you forget to take your Olmeraas CH 20mg/12.5mg Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olmeraas CH 20mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | HEART |


